Tag:
arthritis
Latest Headlines
Latest Headlines
Allergan to enlist new hires in R&D expansion
Allergan has ambitious plans to swell its ranks with the opening of a new R&D facility in the Garden State. The news comes amid a major push at Allergan to expand the use of Botox far beyond fixing facial wrinkles and to develop therapies for a variety of ailments.
Novartis researchers discover promising arthritis molecule
An investigative team subjected 22,000 molecules to a robotic screening test and found one that spurred the development of cartilage-building cells in lab studies.
Novartis drug discovery repairs arthritic knees in mice
Novartis researchers discovered that a compound called kartogenin promoted the repair of damaged cartilage in arthritic mice.
Polysaccharides offer a sweet way to deliver arthritis meds
The RA Warrior, a blog devoted to information about rheumatoid arthritis, takes us on a tour of the Syracuse University lab of Rebecca Bader, assistant professor of biomedical and chemical
Injectable gel promises on-demand, long-term delivery of arthritis medication
An injectable gel developed by researchers at Brigham and Women's Hospital promises to deliver medication for arthritis sufferers exactly when and where they need it. It does the trick by responding
Biogen Idec arthritis model gets personal
Using a patient dataset and some high-horsepower computing, researchers at Biogen Idec ( $BIIB ) and analytics company GNS Healthcare have built a rheumatoid arthritis disease model that lets them run
J&J recalls 400 arthritis treatment pens
Furthering its recall woes, Johnson & Johnson ( $JNJ ) is removing about 400 of its Simponi injection pens from the U.S. and German markets due to a manufacturing flaw that causes the pens to
Lexicon arthritis drug torpedoed by placebo response
Lexicon Pharmaceuticals ( $LXRX ) says its experimental arthritis drug was torpedoed by an unusually high placebo response in a mid-stage study, sending its stock tumbling 14 percent on the news. After
Syracuse researcher takes on better delivery of arthritis meds
Rebecca Bader, an assistant professor of biomedical and chemical engineering at Syracuse University, has watched her aunt’s 41-year battle with rheumatoid arthritis, including countless
Pozen poised for profits after Vimovo wins approval
Shares of Pozen shot up 21 percent on Friday after the FDA sanctioned its new combo therapy for arthritis. Vimovo, developed in partnership with AstraZeneca, contains the NSAID pain drug naproxen
